Actionable targets in patients with cisplatin-resistant advanced germ cell tumours
Actionable targets in patients with cisplatin-resistant advanced germ cell tumours
Post-translational modification (PTM) profiling – a novel tool for mapping the PTM landscape in cancer
Medical cancer prevention
From genotype to molecular phenotype by proteomics
Cancer systems biology
Global cancer partnership
Improving cancer control in low-middle income countries and creating a global network of expertise
Buparlisib helps overcome endocrine resistance in metastatic breast cancer: BELLE-2 trial results
Survival outcomes from the CALGB 40603 study in triple-negative breast cancer
TH3RESA: T-DM1 improves overall survival in previously treated advanced cancer patients
Molecular evolution of breast cancer during neoadjuvant chemotherapy
NSABP FB-7: Neoadjuvant therapy with neratinib plus trastuzumab in locally advanced HER2-positive breast cancer